Task Force on Community Preventive Services, 32186-32187 [2010-13514]

Download as PDF 32186 Federal Register / Vol. 75, No. 108 / Monday, June 7, 2010 / Notices Licensing Status: Available for licensing. Licensing Contacts: Uri Reichman, PhD, MBA; 301–435–4616; UR7a@nih.gov; or Michael Shmilovich, Esq.; 301–435–5019; ShmilovichM@mail.nih.gov. Collaborative Research Opportunity: The National Institute on Aging, Laboratory of Neurosciences-Receptor Pharmacology Unit, is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize this technology. Please contact John Hewes, PhD at 301–435– 3131 or hewesj@mail.nih.gov for more information. Inventors: Judit A. Quasney, Franklin Koh, John P. Jenkins, Robert M. Alexander, Daniel P. O’Brien (NIAID). Patent Status: U.S. Patent Application No. 12/764,872 filed 21 Apr 2010 (HHS Reference No. E–102–2010/0–US–01) Licensing Status: Available for licensing. Licensing Contact: Michael A. Shmilovich, Esq.; 301–435–5019; shmilovm@mail.nih.gov. Software System for Analysis of Extremely Large Experimental Dataset and Multidimensional Drug Discovery WReier-Aviles on DSKGBLS3C1PROD with NOTICES federally-funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing. ADDRESSES: Licensing information and copies of the U.S. patent applications listed below may be obtained by writing to the indicated licensing contact at the Office of Technology Transfer, National Institutes of Health, 6011 Executive Boulevard, Suite 325, Rockville, Maryland 20852–3804; telephone: 301/ 496–7057; fax: 301/402–0220. A signed Confidential Disclosure Agreement will be required to receive copies of the patent applications. Sound Attenuation Canopy for Reducing Noise Transmitted Through Suspended Ceilings BILLING CODE 4140–01–P Description of Invention: This invention is a computer software suite that will enable its user to investigate extremely large experimental datasets in a simple yet multidimensional manner. The software, Omnimorph, allows multidimensional investigation of any form of data including experimental datasets in biomedical science using either gene arrays or proteomics. Omnimorph allows the user to look for extremely subtle correlated differences between experimental datasets which will allow the investigator to discover far more drug- or disease-specific factors than other analytical methods currently used. The software of present invention has been employed in the targeted discovery of G protein-independent receptor-based pharmacotherapeutics. These discoveries represent an entirely new GPCR-based G protein-independent pharmacopeia. Therefore, the Omnimorph is not only newly developed software, but the Omnimorph suite can also be used as a simple and unbiased tool to detect novel and unexpected modes of GPCR-based drug actions. This could potentially alter the way drugs are developed and screened in the future. Applications: • Development and screen for pharmaceutical drugs. • Biomedical research. Development Status: • The invention has been fully developed. • The software will be readily available if so requested. Inventors: Stuart R. Maudsley et al. (NIA). Patent Status: HHS Reference No. E– 143–2010/0—Research Tool. Patent protection is not being pursued for this technology. Description of Invention: Available for licensing and commercial implementation in commercial facilities design and construction are intellectual property rights covering a sound attenuation canopy for reducing noise transmitted through suspended ceiling systems commonly used in most office buildings. The canopy is designed to absorb sound energy and effectively reduce the direct path of sound travelling within open plenum suspended ceilings like those used in most office building environments. The canopy can also act as an umbrella to shield loose debris and dust which may be located in the plenum and potentially fall when ceiling suspended return-air grilles are moved or accessed. The canopy has an added benefit of reducing heating or cooling loss which may naturally ventilate through the return air plenum grille from a conditioned office space below. Also, the canopy controls leakage of heating and cooling, reducing loads on the central building systems thereby lessening energy costs and extending the life-cycle of the building’s physical plant. The canopy does not impede natural air flow for ventilating the plenum cavity but deters the spread of smoke or fire between the plenum and the office space below. The canopy can also act as a secondary air balancer or K Factor balancer to equate supply and return air to control room temperature. The canopy is pliable and therefore allows for ease of adjustment within varying plenum conditions as well as readily installed in ceiling plenums. Applications: • Building design and construction. • Sound attenuation. • Energy load reduction. VerDate Mar<15>2010 15:27 Jun 04, 2010 Jkt 220001 PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 Dated: June 1, 2010. Richard U. Rodriguez, Director, Division of Technology Development and Transfer, Office of Technology Transfer, National Institutes of Health. [FR Doc. 2010–13597 Filed 6–4–10; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Task Force on Community Preventive Services Name: Task Force on Community Preventive Services meeting. Times and Dates: 8 a.m.–5:30 p.m. EST, June 16, 2010. 8 a.m.–1 p.m. EST, June, 17, 2010. Place: Centers for Disease Control and Prevention, 2500 Century Center, Atlanta, GA 30329. Status: Open to the public, limited only by space available. Purpose: The mission of the Task Force is to develop and publish the Guide to Community Preventive Services (Community Guide), which is based on the best available scientific evidence and current expertise regarding essential public health and what works in the delivery of those services. Matters to be discussed: (1) Updates of prior reviews on the following topics: Reducing Vaccine-Preventable Diseases; Increasing Screening for Breast, Cervical, and Colorectal Cancer. (2) New reviews on: Immunization Information Systems; Collaborative Care for the Management of Depressive Disorders and Communication Campaigns with Product Distribution. Agenda items are subject to change as priorities dictate. Contact person or additional information: Freda Parker, Community Guide Branch, Centers for Disease Control and Prevention, 1600 Clifton Road, M/S E–69, Atlanta, GA 30333, phone: 404.498.1119. E:\FR\FM\07JNN1.SGM 07JNN1 Federal Register / Vol. 75, No. 108 / Monday, June 7, 2010 / Notices Dated: May 28, 2010. Tanja Popovic, Associate Director for Science, Centers for Disease Control and Prevention. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2010–13514 Filed 6–4–10; 8:45 am] National Center for Research Resources; Notice of Closed Meetings National Institutes of Health BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Research Resources: Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. WReier-Aviles on DSKGBLS3C1PROD with NOTICES Name of Committee: National Center for Research Resources Special Emphasis Panel; CTSA Renewal. Date: October 13–14, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Rockville, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Mohan Viswanathan, PhD, Deputy Director, Office of Review, National Center for Research Resources, National Institutes of Health, 6701 Democracy Blvd., Dem. 1, Room 1084, MSC 4874, Bethesda, MD 20892–4874, 301–435–0829, mv10f@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research; 93.371, Biomedical Technology; 93.389, Research Infrastructure; 93.306, 93.333; 93.702, ARRA Related Construction Awards, National Institutes of Health, HHS) Dated: June 1, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–13582 Filed 6–4–10; 8:45 am] BILLING CODE 4140–01–P VerDate Mar<15>2010 15:27 Jun 04, 2010 Jkt 220001 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Research Resources Special Emphasis Panel; NCRR SBIR2 Contract Review. Date: June 30, 2010. Time: 8 a.m. to 12 p.m. Agenda: To review and evaluate contract proposals. Place: Bethesda Marriott Suites, 6711 Democracy Blvd., Executive Board Room, Bethesda, MD 20817. Contact Person: Guo Zhang, PhD, MD, Scientific Review Administrator, National Center for Research Resources, or National Institutes of Health, 6701 Democracy Boulevard, 1 Democracy Plaza, Room 1064, MSC 4874, Bethesda, MD 20892–4874, 301– 435–0812, zhanggu@mail.nih.gov. Name of Committee: National Center for Research Resources Special Emphasis Panel; Conference Grants 2010. Date: July 15, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Bethesda, MD 20892. Contact Person: Lee Warren Slice, PhD, Scientific Review Officer, Office of Review, National Center for Research Resources, Bethesda, MD 20892, 301–435–0965. Name of Committee: National Center for Research Resources Special Emphasis Panel. Date: July 20, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Rockville, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Sheri A. Hild, PhD, Scientific Review Officer, National Institutes of Health, National Center for Research Resources, Office of Review, 6701 Democracy Blvd, Rm. 1082, Bethesda, MD 20892, 301– 435–0811, hildsa@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research; 93.371, Biomedical PO 00000 Frm 00030 Fmt 4703 Sfmt 9990 32187 Technology; 93.389, Research Infrastructure; 93.306, 93.333; 93.702, ARRA Related Construction Awards, National Institutes of Health, HHS) Dated: June 1, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–13579 Filed 6–4–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Research Resources; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Research Resources Special Emphasis Panel. Date: July 13, 2010. Time: 1 p.m. to 2 p.m Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Democracy II, 6701 Democracy Blvd., 1074, Bethesda, MD 20892. Contact Person: Lisa A. Newman, SCD, Scientific Review Officer, National Institutes of Health, National Center for Research Resources, Office of Review, Room 1074, 6701 Democracy Blvd., MSC 4874, Bethesda, MD 20892, 301–435–0965, newmanla2@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research; 93.371, Biomedical Technology; 93.389, Research Infrastructure; 93.306, 93.333, 93.702, ARRA Related Construction Awards, National Institutes of Health, HHS) Dated: June 1, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–13576 Filed 6–4–10; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\07JNN1.SGM 07JNN1

Agencies

[Federal Register Volume 75, Number 108 (Monday, June 7, 2010)]
[Notices]
[Pages 32186-32187]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-13514]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Task Force on Community Preventive Services

    Name: Task Force on Community Preventive Services meeting.
    Times and Dates: 8 a.m.-5:30 p.m. EST, June 16, 2010. 8 a.m.-1 p.m. 
EST, June, 17, 2010.
    Place: Centers for Disease Control and Prevention, 2500 Century 
Center, Atlanta, GA 30329.
    Status: Open to the public, limited only by space available.
    Purpose: The mission of the Task Force is to develop and publish 
the Guide to Community Preventive Services (Community Guide), which is 
based on the best available scientific evidence and current expertise 
regarding essential public health and what works in the delivery of 
those services.
    Matters to be discussed: (1) Updates of prior reviews on the 
following topics: Reducing Vaccine-Preventable Diseases; Increasing 
Screening for Breast, Cervical, and Colorectal Cancer.
    (2) New reviews on: Immunization Information Systems; Collaborative 
Care for the Management of Depressive Disorders and Communication 
Campaigns with Product Distribution.
    Agenda items are subject to change as priorities dictate.
    Contact person or additional information: Freda Parker, Community 
Guide Branch, Centers for Disease Control and Prevention, 1600 Clifton 
Road, M/S E-69, Atlanta, GA 30333, phone: 404.498.1119.


[[Page 32187]]


    Dated: May 28, 2010.
Tanja Popovic,
Associate Director for Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2010-13514 Filed 6-4-10; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.